About Savolitinib Savolitinib is an oral, potent, and highly selective MET TKI that has demonstrated clinical…
About Aumolertinib Aumolertinib (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M…
About Furmonertinib Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral…
About Pyrotinib Irene (Pyrotinib) sold under the brand name 艾瑞妮 in china, Pyrotinib is an irreversible dual…
About Febuxostat Febuxostat is used to lower hyperuricemia (high uric acid in the blood) in patients…
About Belzutifan Belzutifan is an hypoxia-inducible factor-2 alpha inhibitor. Belzutifan is used to treat von Hippel-Lindau…
About Apalutamide Apalutamide is a nonsteroidal antiandrogen medication used for the treatment of prostate cancer. It…
About Tepotinib Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping…
About Ivonescimab Ivonescimab is the most advanced PD-1/VEGF bispecific antibody in clinical development in the U.S.,…
About Olaparib Olaparib is a poly (ADP ribose) polymerase (PARP) inhibitor, at least before monotherapy Germline…
About Fruquintinib Fruquintinib (Fruzaqla) sold under the brand name 爱优特 in china, is an oral, highly selective,…
About Toripalimab Toripalimab-tpzi is a next generation anti-PD-1 monoclonal antibody that blocks PD-L1 binding to the…
About Glumetinib or Gumarontinib Glumetinib (SCC244) also named Gumarontinib， is a highly selective, orally bioavailable, ATP-competitive c-Met…
About Adagrasib Adagrasib is a prescription medicine used in adults: alone to treat non-small cell lung…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
About Pralsetinib Pralsetinib is a tyrosine kinase inhibitor. It is taken by mouth. Pralsetinib is a medication approved for RET mutation-positive medullary…
Copyright © 2021-2022 LienTeh.net All rights reserved.
